Make your own cigarettes: Toxicant exposure, smoking topography, and subjective effects

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 9, 2014, Pages 1793-1803

  Koszowski, Bartosz ^a   Rosenberry, Zachary R ^a   Viray, Lauren C ^a   Potts, Jennifer L ^a   Pickworth, Wallace B ^a  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; NICOTINE; TOBACCO SMOKE;

ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATION; LABORATORY TEST; MAKE YOUR OWN CIGARETTE; MALE; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TOPOGRAPHY; VELOCITY; ADVERSE EFFECTS; ANALYSIS; BLOOD; INTOXICATION; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; TOBACCO; TOBACCO USE DISORDER; UNITED STATES;

ADULT; BALTIMORE; FEMALE; HUMANS; MALE; NICOTINE; SMOKING; TOBACCO PRODUCTS; TOBACCO USE DISORDER;

EID: 84907164574     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0280     Document Type: Article

References (59)

1. Centers for Disease Control and Prevention. Drop in cigarette consumption offset by increases in other forms of smoked tobacco. 2012. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6130a1.htm
2. Hanewinkel R, Isensee B. Opinion on tobacco tax increase: factors associated with individuals' support in Germany. Health Policy 2008; 86: 234-8.
3. Young D, Yong HH, Borland R, Shahab L, Hammond D, Cummings KM, et al. Trends in roll-your-own smoking: findings from the ITC Four-Country Survey (2002-2008). J Environ Public Health 2012; 2012: 1-7.
4. Rosenberry ZR, Strasser AA, Canlas LL, Potts JL, Pickworth WB. Make your own cigarettes: characteristics of the product and the consumer. Nicotine Tob Res 2013; 15: 1453-7.
5. Darrall KG, Figgins JA. Roll-your-own smoke yields: theoretical and practical aspects. Tob Control 1998; 7: 168-75.
6. Shahab L, West R, McNeill A. The feasibility of measuring puffing behaviour in roll-your-own cigarette smokers. Tob Control 2008; 17 Suppl 1: i17-23.
7. Shahab L, West R, McNeill A. A comparison of exposure to carcinogens among roll-your-own and factory-made cigarette smokers. Addict Biol 2009; 14: 315-20.
8. Ayo-Yusuf OA, Olutola BG. 'Roll-your-own' cigarette smoking in South Africa between 2007 and 2010. BMC Public Health 2013; 13: 597.
9. Benjakul S, Termsirikulchai L, Hsia J, Kengganpanich M, Puckcharern H, Touchchai C, et al. Current manufactured cigarette smoking and roll-your-own cigarette smoking in Thailand: findings from the 2009 Global Adult Tobacco Survey. BMC Public Health 2013; 13: 277.
10. International Organization for Standardization. Routine analytical cigarette- smoking machine-definitions and standard conditions: ISO 3308: 2012. 2012.
11. Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev 2005; 14: 1370-5.
12. Bridges RB, Combs JG, Humble JW, Turbek JA, Rehm SR, Haley NJ. Puffing topography as a determinant of smoke exposure. Pharmacol Biochem Behav 1990; 37: 29-39.
13. Strasser AA, Ashare RL, Kozlowski LT, Pickworth WB. The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacol Biochem Behav 2005; 82: 320-9.
14. Lee EM, Malson JL, Waters AJ, Moolchan ET, Pickworth WB. Smoking topography: reliability and validity in dependent smokers. Nicotine Tob Res 2003; 5: 673-9.
15. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA. The reliability of puff topography and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res 2012; 14: 490-4.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
17. Shiffman S, Waters A, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 2004; 6: 327-48.
18. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 2001; 3: 7-16.
19. Tiffany ST, Drobes DJ. The development and initial validation of a Questionnaire on Smoking Urges. Br J Addict 1991; 86: 1467-76.
20. West R, Ussher M. Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? Psychopharmacology (Berl) 2010; 208: 427-32.
21. Behm FM, Rose JE. Reducing craving for cigarettes while decreasing smoke intake using capsaicin-enhanced low-tar cigarettes. Exp Clin Psychopharmacol 1994; 2: 143-53.
22. Westman EC, Levin ED, Rose JE. Smoking while wearing the nicotine patch: is smoking satisfying or harmful? Clin Res 1992; 40: 871A.
23. Pickworth WB, Moolchan ET, Berlin I, Murty R. Sensory and physiologic effects of menthol and non-menthol cigarettes with differing nicotine delivery. Pharmacol Biochem Behav 2002; 71: 55-61.
24. Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav 2000; 67: 71-81.
25. Malson JL, Lee EM, Moolchan ET, Pickworth WB. Nicotine delivery from smoking bidis and an additive-free cigarette. Nicotine Tob Res 2002; 4: 485-90.
26. Malson JL, Lee EM, Murty R, Moolchan ET, Pickworth WB. Clove cigarette smoking: biochemical, physiological, and subjective effects. Pharmacol Biochem Behav 2003; 74: 739-45.
27. Malson JL, Pickworth WB. Bidis-hand-rolled, Indian cigarettes: effects on physiological, biochemical and subjective measures. Pharmacol Biochem Behav 2002; 72: 443-7.
28. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob Res 1999; 1: 357-64.
29. Muhammad-Kah RS, Hayden AD, Liang Q, Frost-Pineda K, Sarkar M. The relationship between nicotine dependence scores and biomarkers of exposure in adult cigarette smokers. Regul Toxicol Pharmacol 2011; 60: 79-83.
30. Lindner D, Smith S, Leroy CM, Tricker AR. Comparison of exposure to selected cigarette smoke constituents in adult smokers and nonsmokers in a European, multicenter, observational study. Cancer Epidemiol Biomarkers Prev 2011; 20: 1524-36.
31. Zhang Q, Li L, Smith M, Guo Y, Whitlock G, Bian Z, et al. Exhaled carbon monoxide and its associations with smoking, indoor household air pollution and chronic respiratory diseases among 512000 Chinese adults. Int J Epidemiol 2013; 42: 1464-75.
32. Scherer G. Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Exp Toxicol Pathol 2006; 58: 101-24.
33. Zielinska-Danch W, Goniewicz ML, Szoltysek-Boldys I, Czogala J, Koszowski B, Slodczyk E, et al. [Estimation of optimal levels of tobacco biomarkers to distinguish active and passive smokers using ROC analysis]. Przegl Lek 2009; 66: 636-40.
34. Bausell RB, Li Y. Power analysis for experimental research: a practical guide for biological, medical, and social sciences. New York: Cambridge University Press; 2002.
35. Pickworth WB, Houlgate P, Schorp M, Dixon M, Borgerding M, Zaatari G. A review of human smoking behaviour data and recommendations for a new ISO standard for the machine smoking of cigarettes.AReport of the Ad Hoc WG9 Smoking Behaviour Review Team to ISO/TC 126 WG9; 2005.
36. Broms U, Madden PA, Heath AC, Pergadia ML, Shiffman S, Kaprio J. The Nicotine Dependence Syndrome Scale in Finnish smokers. Drug Alcohol Depend 2007; 89: 42-51.
37. Okuyemi KS, Pulvers KM, Cox LS, Thomas JL, Kaur H, Mayo MS, et al. Nicotine dependence among African American light smokers: a comparison of three scales. Addict Behav 2007; 32: 1989-2002.
38. Clark DB, Wood DS, Martin CS, Cornelius JR, Lynch KG, Shiffman S. Multidimensional assessment of nicotine dependence in adolescents. Drug Alcohol Depend 2005; 77: 235-42.
39. Fabian LA, Canlas LL, Potts J, PickworthWB. Ad lib smoking of Black & Mild cigarillos and cigarettes. Nicotine Tob Res 2012; 14: 368-71.
40. Czogala J, Goniewicz ML, Czubek A, Koszowski B, Sobczak A. ["How does smoker really smoke?"-preliminary report on smoking topography among Polish smokers]. Przegl Lek 2008; 65: 657-62.
41. Djordjevic MV, Stellman SD, Zang E. Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst 2000; 92: 106-11.
42. Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2004; 13: 1800-4.
43. Franken FH, Pickworth WB, Epstein DH, Moolchan ET. Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2006; 15: 154-7.
44. Pickworth WB, Lee EM, Abreu ME, Umbricht A, Preston KL. A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users. Pharmacol Biochem Behav 2004; 77: 711-5.
45. Gust SW, Pickens RW, Pechacek TF. Relation of puff volume to other topographical measures of smoking. Addict Behav 1983; 8: 115-9.
46. Guyatt AR, Kirkham AJ, Baldry AG, Dixon M, Cumming G. How does puffing behavior alter during the smoking of a single cigarette? Pharmacol Biochem Behav 1989; 33: 189-95.
47. Kolonen S, Tuomisto J, Puustinen P, Airaksinen MM. Puffing behavior during the smoking of a single cigarette in a naturalistic environment. Pharmacol Biochem Behav 1992; 41: 701-6.
48. Veilleux JC, Kassel JD, Heinz AJ, Braun A, Wardle MC, Greenstein J, et al. Predictors and sequelae of smoking topography over the course of a single cigarette in adolescent light smokers. J Adolesc Health 2011; 48: 176-81.
49. Collins CC, Epstein DH, Parzynski CS, Zimmerman D, Moolchan ET, Heishman SJ. Puffing behavior during the smoking of a single cigarette in tobacco-dependent adolescents. Nicotine Tob Res 2010; 12: 164-7.
50. Fant RV, Pickworth WB, Henningfield JE. The addictive effects of nicotine are related to the speed of delivery. In: Opitz K, editor. Nicotine as a therapeutic agent, immunity and the environment. Stuttgart: Gustav-Fisher; 1997. p. 53-61.
51. Pickworth WB, Henningfield JE. Smokable drugs: pharmacologic basis for consumer appeal. Addiction 1997; 92: 691-2.
52. Rose JE, Behm FM. There is more to smoking than the CNS effects of nicotine. In: Adlkofer F, Thurau K, editors. Effects of nicotine on biological systems II. Advances in pharmacologic sciences. Birkhauser: Springer-Verlag; 1991. p. 239-46.
53. Robinson ML, Houtsmuller EJ, Moolchan ET, Pickworth WB. Placebo cigarettes in smoking research. Exp Clin Psychopharmacol 2000; 8: 326-32.
54. Blank MD, Disharoon S, Eissenberg T. Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res 2009; 11: 896-903.
55. Nosa V, Glover M, Min S, Scragg R, Bullen C, McCool J, et al. The use of the 'rollie' in New Zealand: preference for loose tobacco among an ethnically diverse low socioeconomic urban population. N Z Med J 2011; 124: 25-33.
56. Young D, Wilson N, Borland R, Edwards R, Weerasekera D. Prevalence, correlates of, and reasons for using roll-your-own tobacco in a high RYO use country: findings from the ITC New Zealand survey. Nicotine Tob Res 2010; 12: 1089-98.
57. Young D, Borland R, Hammond D, Cummings KM, Devlin E, Yong HH, et al. Prevalence and attributes of roll-your-own smokers in the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006; 15 Suppl 3: iii76-82.
58. Kaiserman MJ, Rickert WS. Handmade cigarettes: it's the tube that counts. Am J Public Health 1992; 82: 107-9.
59. Kaiserman MJ, Rickert WS. Carcinogens in tobacco smoke: benzo[ a]pyrene from Canadian cigarettes and cigarette tobacco. Am J Public Health 1992; 82: 1023-6.